Accelerate Diagnostics reports Q1 2018 financial results
May 10, 2018
Accelerate Diagnostics, Inc. today announced financial results for the quarter ending March 31, 2018. The company generated revenue of $801,000, up 51% from the prior year, and reported signed agreements for 345 instruments. Contracts for customer evaluations total 256 instruments while revenue generating placements grew to 89 across the U.S. and European regions.
See the company’s press release for additional details.
- Accelerate Diagnostics Expands Antimicrobials in New CE-Marked Accelerate PhenoTest™ BC kit
Aug 02, 2019
- Accelerate Diagnostics announces preliminary 2018 fourth quarter and full-year financial results
Jan 06, 2019